Stock RIGL RIGEL PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News Rigel Pharmaceuticals, Inc.

Equities

RIGL

US7665597024

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-07-10 pm EDT 		5-day change 1st Jan Change
8.59 USD +5.53% Intraday chart for Rigel Pharmaceuticals, Inc. +11.13% -40.76%
Jun. 25 Rigel Pharmaceuticals to Implement 1-for-10 Reverse Stock Split MT
Jun. 25 Sector Update: Health Care Stocks Advance Pre-Bell Tuesday MT

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Reverse Split: 1 of 10
FA
Rigel Pharmaceuticals to Implement 1-for-10 Reverse Stock Split
MT
Sector Update: Health Care Stocks Advance Pre-Bell Tuesday
MT
Rigel Announces Reverse Stock Split
PR
Rigel Pharmaceuticals Completes Transfer of Gavreto New Drug Application
MT
Rigel Pharmaceuticals Completes Transfer of GAVRETO®? (pralsetinib) New Drug Application
CI
Rigel Announces Five Presentations at the EHA2024 Hybrid Congress
AQ
Rigel Pharmaceuticals, Inc. Announces Five Presentations at the EHA2024 Hybrid Congress
CI
Rigel to Present at the Jefferies Global Healthcare Conference
PR
Rigel: Q1 Earnings Snapshot
AQ
Transcript : Rigel Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 07, 2024
Earnings Flash (RIGL) RIGEL PHARMACEUTICALS Posts Q1 Revenue $29.5M, vs. Street Est of $31.5M
MT
Rigel Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Rigel Announces Conference Call and Webcast to Report First Quarter 2024 Financial Results and Business Update
PR
Rigel Pharmaceuticals : March 2024
PU
Rigel Pharmaceuticals, Inc. Enters into Amendment No. 4 to that Certain Credit and Security Agreement
CI
Rigel Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
PR
Rigel Announces Publication of Data on REZLIDHIA in Post-Venetoclax Patients with Mutant IDH1 AML in Leukemia and Lymphoma
AQ
Rigel Pharmaceuticals Announces Appointment of Lisa Rojkjaer, M.D. as Chief Medical Officer
PR
Rigel Pharmaceuticals Announces Appointment of Lisa Rojkjaer as Chief Medical Officer
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. RIGL Stock
  4. News Rigel Pharmaceuticals, Inc.